Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Bladder transitional cell carcinoma: Which Medications Are Safest? (96 Drugs Compared)

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

96 medications are used for Bladder transitional cell carcinoma, with 1,484 combined adverse event reports. The most reported drugs for Bladder transitional cell carcinoma are GEMCITABINE and CISPLATIN.

1,484
Total Reports
96
Drugs Used

All Medications for Bladder transitional cell carcinoma Ranked by Safety Reports

Drug Brand Reports Deaths (all) Hosp. (all) Death Rate
GEMCITABINE Gemcitabine 335 5,142 12,268 16.4%
CISPLATIN CISplatin 252 8,387 17,469 17.7%
PEMBROLIZUMAB KEYTRUDA 251 15,543 35,472 18.6%
ATEZOLIZUMAB Tecentriq Hybreza 195 8,520 15,094 25.3%
CARBOPLATIN Carboplatin 146 12,544 35,869 14.9%
BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN TICE BCG 119 69 353 3.6%
AVELUMAB BAVENCIO 104 861 1,630 23.7%
DURVALUMAB IMFINZI 88 5,088 5,968 29.7%
NIVOLUMAB OPDIVO 80 23,086 36,530 26.3%
ENFORTUMAB VEDOTIN-EJFV - 68 747 1,149 20.0%
GEMCITABINE\GEMCITABINE - 68 2,206 3,666 21.6%
DOXORUBICIN Doxorubicin Hydrochloride 56 15,653 28,630 18.9%
METHOTREXATE Methotrexate 51 21,265 68,793 8.4%
TREMELIMUMAB IMJUDO 51 594 1,510 24.9%
BCG VACCINE - 49 55 171 13.2%
VINBLASTINE Vinblastine Sulfate 48 1,018 1,653 18.8%
PACLITAXEL PACLITAXEL PACLITAXEL 47 12,030 31,638 15.6%
BACILLUS CALMETTE-GUERIN ANTIGEN, UNSPECIFIED SUBSTRAIN - 33 45 163 10.8%
MITOMYCIN MUTAMYCIN 33 231 590 10.9%
ENFORTUMAB VEDOTIN PADCEV EJFV 31 278 645 19.5%

View all 96 drugs →

Most Reported Drugs for Bladder transitional cell carcinoma

#1 most reported
#2 most reported
#3 most reported